Isis spin-out Oxford Immunotec goes from strength to strength

24th January 2014

Oxford Immunotec announces preliminary fourth quarter revenues

Isis spin-out Oxford Immunotec, which recently listed on the US’s Nasdaq market, has announced that based on preliminary unaudited financial data, it expects total revenue for the fourth quarter of 2013 will be between US$10.1 and $10.5 million. For the fiscal year 2013, it expects total revenue of between $38.6 million and $39.0 million.

• Preliminary fourth quarter revenue of between $10.1 and $10.5 million, an increase of 91% to 99% over the prior year.

• Preliminary 2013 revenue of between $38.6 and $39.0 million, an increase of 87% to 89% over 2012

• 2014 Revenues expected to be in the range of $47 to $50 million.

Oxford Immunotec was spun out by Isis in 2002.

Read more in the Oxford Immunotec press release.

Press release sign up